ONCSM.E — Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Share Price
0.000.00%
Last trade - 00:00- TRY2.11bn
- TRY2.11bn
- TRY374.49m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.68 | ||
| Price to Tang. Book | 7.82 | ||
| Price to Free Cashflow | 55.67 | ||
| Price to Sales | 5.62 | ||
| EV to EBITDA | 36.58 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.04% | ||
| Return on Equity | -19.44% | ||
| Operating Margin | 1.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TRYm | 101.3 | 127.99 | 292.94 | 347.24 | 374.49 | n/a | n/a | 50.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +827.35 | +242.46 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is a Turkey-based company, which is engaged in the production of medical devices. The Company manufactures electromedical and electrotherapeutic apparatus, surgical and medical instruments, and other related medical products. Oncosem Onkolojik Sistemler is specialized in the manufacturing of equipment and medical devices used in cancer treatment, and it offers fully automated chemotherapy drug preparation devices, diagnostic tests and protective equipment, and waste collection devices. The Company also manufactures hazardous waste sealing systems, chemotherapy preparation and administration consumables, Oncosem devices' components, and infusion pumps.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 5th, 2008
- Public Since
- January 4th, 2023
- No. of Employees
- 292
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Istanbul Stock Exchange
- Shares in Issue
- 23,850,000
- Address
- Mutlukent Mh. 1988 Cd. No: 12 Cankaya, ANKARA, 06510
- Web
- https://oncosem.com/
- Phone
- +90 3122195032
- Auditors
- EREN Bagimsiz Denetim A.S.
Upcoming Events for ONCSM.E
Similar to ONCSM.E
Fonet Bilgi Teknolojileri AS
Istanbul Stock Exchange
Meditera Tibbi Malzeme Sanayi ve Ticaret AS
Istanbul Stock Exchange
Seyitler Kimya Sanayi AS
Istanbul Stock Exchange
FAQ
What is the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS share price?
As of Today at 22:27 UTC, shares in Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS are trading at TRY88.30. This share price information is delayed by 15 minutes.
How has the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS share price performed this year?
Shares in Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS last closed at TRY88.30 and the price had moved by -49.12% over the past 365 days. In terms of relative price strength the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS share price has underperformed the FTSE Global All Cap Index by -50.4% over the past year.
What are the analyst and broker recommendations for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?
There is no consensus recommendation for this security.
Find out moreWhat is the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS dividend yield?
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS does not currently pay a dividend.
Does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pay a dividend?
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS does not currently pay a dividend.
When does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS next pay dividends?
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS does not currently pay a dividend.
How do I buy Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS shares?
To buy shares in Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?
As of the previous close price of TRY88.30, shares in Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS had a market capitalisation of TRY2.11bn.
Where are Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS shares listed?
Here are the trading details for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS:
- Country of listing: Turkey
- Exchange: IST
- Ticker Symbol: ONCSM.E
What kind of share is Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?
Based on an overall assessment of its quality, value and momentum Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -5.23%.
As of the last closing price of TRY88.30, shares in Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS were trading -24.18% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS PE Ratio?
The Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TRY88.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?
We do not have data on Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS' directors